Jul
16,
2024
Jul 16, 2024
Lallemand Pharma has announced a groundbreaking partnership with Avalon Pharma, a dynamic Saudi pharmaceutical firm. Together, they aim to… Read more
Mar
12,
2019
Mar 12, 2019
Lallemand pharma is pleased to announce that Ismigen®, our PMBL® tablets (Polyvalent Mechanical Bacterial Lysates), have been launched by UniMed… Read more
Dec
11,
2017
Dec 11, 2017
December 11, 2017- Massagno, Switzerland — We are pleased to announce that our Pharma partner Schumitt Health Korea LLC has… Read more
Apr
20,
2017
Apr 20, 2017
Play while you wait….Discover Boostic Boy, a mobile game developped by Lallemand Pharma to help improve patients experience in the… Read more
Apr
20,
2017
Apr 20, 2017
Lallemand Pharma is pleased to launch its LinkedIn showcase page, a place where we will be sharing news and events… Read more
Nov
19,
2014
Nov 19, 2014
Spurred by the success of ISMIGEN® in Latin America, Lallemand Pharma and Merck are pleased to announce the launch in… Read more
Nov
13,
2014
Nov 13, 2014
LALLEMAND PHARMA and STADA CIS are pleased to announce the launch on the Russian market of PMBL™ tablets, an immuno-modulating… Read more